Exact Mass: 456.9524
Exact Mass Matches: 456.9524
Found 8 metabolites which its exact mass value is equals to given mass value 456.9524,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-(5-bromo-2-methoxyphenyl)-3-(4-ethoxyphenyl)sulfonyl-1,3-thiazolidine
2-(5-bromo-2-methoxyphenyl)-3-(4-ethoxyphenyl)sulfonyl-1,3-thiazolidine
N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
B-Raf IN 11 (ZINC72115182) is a selective B-RafV600E inhibitor (IC50=76 nM), shows selectivity for B-RafV600E over B-RafWT with selectivity of 3.1-fold. B-Raf IN 11 can be used in colorectal cancer research[1]
6-bromo-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine
6-bromo-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine
3-[6-Bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile
3-[6-Bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile
MB710
MB710
MB710, an aminobenzothiazole derivative, is a stabilizer of oncogenic p53 mutation Y220C. MB710 binds tightly to the Y220C pocket and stabilizes p53-Y220C, with a Kd of 4.1?μM. MB710 shows anticancer activity in p53-Y220C cell lines[1].
(2s)-3-(3-bromo-4-hydroxyphenyl)-n-[2-(3-bromo-4-hydroxyphenyl)ethyl]-2-hydroxypropanimidic acid
(2s)-3-(3-bromo-4-hydroxyphenyl)-n-[2-(3-bromo-4-hydroxyphenyl)ethyl]-2-hydroxypropanimidic acid
